Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 354, Issue 1384, 1999, Pages 721-738

  Austin, D J ^a   Anderson, R M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antibiotic resistance; Epidemiology; Mathematical models; Nosocomial infection; Pharmacodynamics; Transmission dynamics

Indexed keywords

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 0033614341     PISSN: 09628436     EISSN: None     Source Type: Journal    
DOI: 10.1098/rstb.1999.0425     Document Type: Article

References (57)

1. Aeschlimann, J. R., Zervos, M. J. & Rybak, M. J. 1998 Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (Quiupristin-Dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations. Antimicrob. Agents Chemother. 42, 2710-2717.
2. Albert, R. K. & Condie, F. 1981 Hand-washing patterns in medical intensive-care units. New Engl. J. Med. 304, 1465-1468.
3. Anderson, R. M. & May, R. M. 1991 Infectious diseases of humans: dynamics and control. Oxford University Press.
4. Arason, V. A., Kristinsson, K. G., Sigurdsson, J. A., Stefánsdóttir, G., Mölstad, S. & Gudmundsson, S. 1996 Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. Br. Med. J. 313, 387-391.
5. Austin, D. J. & Anderson, R. M. 1999 The transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales. J. Infect. Dis. (In the press.)
6. Austin, D. J., Kakehashi, M. & Anderson, R. M. 1997 The transmision dynamics of antibiotic-resistant bacteria: the relationship between resistance in commensal organisms and antibiotic consumption. Proc. R. Soc. Lond. B 264, 1629-1638.
7. Austin, D. J., Bonten, M. J. N., Slaughter, S., Weinstein, R. A. & Anderson, R. M. 1998a Vancomycin-resistant enterococci in intensive care hospital settings, persistence, dynamics and the impact of infection control measures. Proc. Natl Acad. Sci. USA. (Submitted.)
8. Austin, D. J., White, N. J. & Anderson, R. M. 1998b The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics. J. Theor. Biol. 194, 313-339.
9. Austin, D. J., Kristinsson, K. G. & Anderson, R. M. 1999 The relationship between the volume of drug consumption in human communities and the frequency of antibiotic resistance. Proc. Natl Acad. Sci. USA 96, 1152-1156.
10. Berg, P. H., Voit, E. O. & White, R. L. 1996 A pharmaco-dynamic model for the action of the antibiotic Imipenem on Pseudomonas aeruginosa populations in vitro. Bull. Math. Biol. 58, 923-938.
11. Berk, S. L., Kalbfleisch, J. H. & The Alexander Project Collaborative Group 1996 Antibiotic susceptibility patterns of community-aquired isolates of Moraxella catarrhalis in Western Europe and in the USA. J. Antimicrob. Chemother. 38 (Suppl. A), 85-96.
12. Björkmann, J., Hughes, D. & Andersson, D. I. 1998 Virulence of antibiotic-resistant Salmonella typhimurium. Proc. Natl Acad. Sci. USA 95, 3949-3953.
13. Blower, S. M., Porco, T. C. & Darby, G. 1998 Predicting and preventing the emergence of drug resistance in HSV 2. Nature Med. 4, 573-578.
14. Bonhoeffer, S., May, R. M., Shaw, G. M. & Nowak, M. A. 1996 Virus dynamics and drug treatment. Proc. Natl Acad. Sci. USA 93, 4398-4402.
15. Bonhoeffer, S., Lipsitch, M. & Levin, B. R. 1997 Evaluating treatment protocols to prevent antibiotic resistance. Proc. Natl Acad. Sci. USA 94, 12106-12111.
16. Bonten, M. J., Hayden, M. K., Nathan, C., Van Voorhis, J., Matushek, M., Slaughter, S., Rice, T. & Weinstein, R. A. 1996 Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci. Lancet 348, 1615-1619.
17. Boyce, J. M., Mermel, L. A., Zervos, M. J., Rice, L. B., Potter-Bynoe, G., Giorgio, C. & Medeiros, A. A. 1995 Controlling vancomycin-resistant enterococci. Infect. Control Hosp. Epidemiol. 16, 634-637.
18. Christenson, B., Sylvan, S. L. V. & Noreen, B. 1997 Carriage of multiresistant Streptococcus pneumoniae among children attending day-care centres in the Stockholm area. Scand. J. Infect. Dis. 29, 555-558.
19. Cole, S. T. (and 41 others) 1998 Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
20. Cookson, B. 1995 Aspects of the epidemiology of MRSA in Europe. J. Chemother. 7 (Suppl. 3), 93-98.
21. Cox, R. A. & Conquest, C. 1997 Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. J. Hosp. Infect. 35, 117-27.
22. Doebbelling, B. N., Stanley, G. L., Sheetz, C. T., Pfaller, M. A., Houston, A. K., Annis, L., Li, N. & Wenzel, R. P. 1992 Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive-care units. New Engl. J. Med. 327, 88-93.
23. Drusano, G. L., Jordan, D. E., Rosen, M. & Standiford, H. C. 1993 Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model. Antimicrob. Agents Chemother. 37, 483-490.
24. Frieden, T. R., Munsiff, S. S., Low, D. E., Willey, B. M., Williams, G., Faur, Y., Eisner, W., Warren, S. & Kreisworth, B. 1993 Emergence of vancomycin-resistant enterococci in New York City. Lancet 342, 76-79.
25. Hiramatsu, K., Aritake, N., Hanaki, H., Kawasaki, S., Hosoda, Y., Hori, S., Fukuchi, Y. & Kobayshi, I. 1997 Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350, 1670-1673.
26. Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M. & Markowitz, M. 1995 Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126.
27. Hyatt, J. M., Nix, D. E., Stratton, C. W. & Schentag, J. J. 1995 In vitro pharmacodynamics of piperacillin, piperacillin -tazobactam and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39, 1711-1716.
28. Lenski, R. E. 1997 The cost of antibiotic resistance from the pespective of a bacterium. Ciba Found. Symp. 207, 131-140.
29. Lenski, R. E., Simpson, S. C. & Nguyen, T. T. 1994 Genetic analysis of a plamid-encoded, host-genotype specific enhancement of bacterial fitness. J. Bacteriol. 176, 3140-3147.
30. Levin, B. R., Lipsitch, M., Perot, V., Schrag, S., Antia, R., Simonsen, L., Moore Walker, N. & Stewart, F. M. 1997 The population genetics of antibiotic resistance. Clin. Infect. Dis. 24, S9-S16.
31. Lipsitch, M. & Levin, B. R. 1997 The population dynamics of antimicrobial therapy. Antimicrob. Agents Chemother. 41, 363-373.
32. Livermore, D. M. 1992 Interplay of impermiability and chromasomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36, 2046-2048.
33. Lloyd, A. L. & May, R. M. 1996 Spatial heterogeneity in epidemic models. J. Theor. Biol. 179, 1-11.
34. Löwdin, E., Odenholt, I. & Cars, O. 1998 In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermis. Antimicrob. Agents Chemother. 42, 2739-2744.
35. Massad, E., Lundberg, S. & Yang, H. M. 1993 Modeling and simulating the evolution of resistance against antibiotics. Int. J. Biomed. Comp. 33, 65-81.
36. Mehtar, S. 1995 Infection control programmes - are they cost- effective? J. Hosp. Infect. 30S, 26-34.
37. Morris, J. G. Jr. Shay, D. K., Hebden, J. N., McCarter, R. J. Jr, Perdue, B. E., Jarvis, W., Johnson, J. A., Dowling, T. C., Polish, L. B. & Schwalbe, R. S. 1995 Enterococci resistant to multiple antimicrobial agents, including vancomycin, establishment of endemicity in a University Medical Center. Ann. Intern. Med. 123, 250-259.
38. Nahwani, D. & Wood, M. J. 1993 Penicillins. A current view of their clinical pharmacology and therapeutic use. Drugs 45, 866-894.
39. Nasell, I. 1997 The quasi-stationary distribution of the closed endemc SIS model. Adv. Appl. Prob. 28, 895-932.
40. Nissinen, A. (and 9 others) 1995 Development of β-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children. Clin. Inject. Dis. 21, 1193-1196.
41. PHLS 1996 Vancomycin-resistant enterococci in hospitals in the United Kingdom - 1995. CDR Weekly 6, 1.
42. PHLS 1997 Epidemic methicillin-resistant Staphylococcus aureus. CDR Weekly 7, 191.
43. Press, W. H., Teukolsky, S. A., Vetterling, W. T. & Flannery, B. P. 1992 Numerical recipes in Fortran. Cambridge University Press.
44. Renshaw, E. 1991 Modelling biological populations in space and time. Cambridge University Press.
45. Rowland, M. & Tozer, T. N. 1995 Clinical pharmacokinetics, concepts and applications. Williams & Wilkins.
46. Salyers, A. A. & Whitt, D. D. 1994 Bacterial pathogenesis, a molecular approach. Washington, DC: American Society for Microbiology.
47. Sanchez, V., Vazquez, J. A., Barth-Jones, D., Dembry, L., Sobel, J. D. & Zervos, M. J. 1992 Epidemiology of nosocomial acquisition of Candida lusitaniae. J. Clin. Microbiol. 30, 3005-3008.
48. Schrag, S. J., Perrot, V. & Levin, B. R. 1997 Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc. R. Soc. Lond. B 264, 1287-1291.
49. Sebille, V., Chevret, S. & Valleron, A. J. 1997 Modelling the spread of resistant nosocomial pathogens in intensive-care units. Infect. Control Hosp. Epidemiol. 18, 84-92.
50. Seppälä, H., Klaúkk T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K. & Huovinen, P. 1997 The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in Group A streptococci in Finland. New Engl. J. Med. 337 441-446.
51. Shay, D. K., Goldmann, D. A. & Jarvis, W. R. 1995 Reducing the spread of antimicrobial-resistant organisms. Control of vancomycin-resistant enterococci. Pediatr. Clin. N. Am. 42, 703-716.
52. Shigesada, N. & Kawasaki, K. 1997 Biological invasions, theory and practice. Oxford University Press.
53. Simmons, B., Bryant, J., Neiman, K., Spencer, L. & Arheart, K. 1990 The role of hand-washing in prevention of endemic intensive-care unit infections. Infect. Control Hosp. Epidemiol. 11, 589-594.
54. Stilianakis, N. I., Perelson, A. S. & Hayden, F. G. 1998 Emergence of drug resistance during an influenza epidemic, insights from a mathematical model. J. Infect. Dis. 177, 863-873.
55. Tabaqchali, S. 1997 Vancomycin-resistant Staphylococcus aureus, apocalypse now? Lancet 350, 1644-1645.
56. Tenover, F. C. & McGowan, J. E. Jr 1996 Reasons for the emergence of antibiotic resistance. Am. J. Med. Sci. 311, 9-16.
57. Wei, X. (and 11 others) 1995 Viral dynamics in human immuno-deficiency virus type 1 infection. Mature 373, 117-122.